Real Goods Solar, Inc.  

(Public, NASDAQ:RGSE)   Watch this stock  
Find more results forNASDAQ:RSOL
2.39
+0.03 (1.06%)
Jul 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.30 - 2.40
52 week 1.70 - 5.65
Open 2.37
Vol / Avg. 373,989.00/929,564.00
Mkt cap 107.47M
P/E     -
Div/yield     -
EPS -0.57
Shares 44.97M
Beta 1.27
Inst. own 35%

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -66.96% -11.15%
Operating margin -44.86% -12.18%
EBITD margin - -9.19%
Return on average assets -102.53% -26.26%
Return on average equity -477.69% -315.03%
Employees 488 -
CDP Score - -

Address

833 WEST SOUTH BOULDER ROAD
LOUISVILLE, CO 80027
United States - Map
+1-303-2223600 (Phone)
+1-303-2228323 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Real Goods Solar, Inc. is a solar energy company. The Company serves commercial, residential, and utility customers. The Company provides a solar solution, from design, financing, permitting and installation to ongoing monitoring, maintenance and support. The Company offers free home solar quotes, as well as solar system financing, design, engineering, permitting, installation, rebate acquisition, maintenance, and monitoring. Effective May 14, 2014, the Company acquired Elemental Energy LLC, doing business as Sunetric.

Officers and directors

David L. Belluck Chairman of the Board
Age: 51
Bio & Compensation  - Reuters
Kamyar Mofid Chief Executive Officer, Director
Age: 45
Bio & Compensation  - Reuters
Tony DiPaolo Chief Financial Officer, Secretary
Age: 54
Bio & Compensation  - Reuters
John Schaeffer Director ,General Manager- Retail & Distribution
Age: 66
Bio & Compensation  - Reuters
Pavel Bouska Director
Age: 60
Bio & Compensation  - Reuters
Ian Bowles Director
Age: 47
Bio & Compensation  - Reuters
Robert Lee Scott Director
Age: 66
Bio & Compensation  - Reuters
Richard D. White Director
Age: 59
Bio & Compensation  - Reuters
Steven B. Kaufman Independent Director
Age: 48
Bio & Compensation  - Reuters